A fast moving megatrial for coronavirus treatments, and transferring the benefits of exercise by transferring blood | Science


Contributing correspondent Kai Kupferschmidt talks with host Sarah Crespi about the success of a fast moving megatrial for coronavirus treatments. The United Kingdom’s Recovery (Randomized Evaluation of COVID-19 Therapy) trial has enrolled more than 12,000 hospitalized coronavirus patients since early March and has released important recommendations that were quickly taken up by doctors and scientists around the world. Kupferschmidt discusses why such a large study is necessary and why other large drug trials like the World Health Organization’s Solidarity trial are lagging behind.

Read Science’s coronavirus coverage.

Also this week, producer Meagan Cantwell talks with Saul Villeda, a professor in the Department of Anatomy at the University of California, San Francisco, about transferring the beneficial effects of exercise on the brain from an active mouse to a sedentary mouse by transferring their blood.

This week’s episode was produced with help from Podigy.

Listen to previous podcasts

About the Science Podcast

Download a transcript (PDF)


Next Post

Palo Alto Networks fixes another severe flaw in PAN-OS devices

Thu Jul 9 , 2020
Palo Alto Networks (PAN) today addressed another severe vulnerability found in the PAN-OS GlobalProtect portal and affecting unpatched PAN next-generation firewalls. On June 29, PAN also patched a critical vulnerability (CVE-2020-2021) with a 10/10 CVSSv3 rating, allowing unauthenticated network-based attackers to bypass authentication on PAN-OS devices with SAML auth enabled […]